Torrent has to its credit, leading brands in various therapeutic segments. It is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Gastro-Intestinal, Diabetology, Anti-infectives and Pain Management. Efforts are on to increase its salience in other therapeutic areas as well. In the domestic market, the focus is exclusively on ethical allopathic market and the higher end of the institutional market in urban and semi-urban areas.

To sharpen its focus and enhance its customer reach in the domestic market, Torrent operates through sales and marketing divisions structured on specific Therapeutic areas. Currently, it has 11 sales and marketing divisions- Vista, Prima, Delta, Psycan, Azuca, Mind, Axon, Neuron, Omega, Sensa and Alfa, each of which have a clear therapeutic focus.

Torrent Pharma promotes various platforms for knowledge sharing including conferences for doctors. It continues its efforts towards customer education on various diseases and their symptoms and cures, thereby increasing customer awareness.

In-licensing deal with Tasly
Torrent Pharma recently entered into an agreement with Tasly, one of China’s largest pharma companies, to exclusively market their blockbuster drug, Cardio-tonic pill, in India.

This in-licensing deal is first of its kind in India in the traditional medicine segment. The Cardiotonic Pill is expected to become the most preferred “add on” therapy in CV disorders and finds perfect synergy with Torrent’s dominant position in the Indian cardio-diabeta (C&D) market.

(Read full press release on Torrent Pharma’s in-licensing deal with Tasly)